This chapter does not limit or affect the right of an individual to practice a health occupation that the individual is authorized to practice. In this chapter, the following terms have the meanings indicated. Terms Defined. “Board” means the State Board of Pharmacy. “Pharmacist” means an individual who practices pharmacy regardless of the location where the activities of practice are performed. “Pharmacy” means an establishment holding a permit under Health Occupations Article, §12-401, Annotated Code of Maryland. “Pharmacy permit holder” means a person authorized by the Board to operate a pharmacy while the pharmacy permit is effective. “Pharmacy Experiential Program” means a program under the American Council on Pharmacy Education. “Practice pharmacy” means to engage in the activities set forth in Health Occupations Article, §12-101(x)(1), Annotated Code of Maryland. “Primary care provider” means a health care practitioner who provides an individual’s primary care services and is the primary coordinator of health care services for the individual. “Vaccination” means: A vaccination that is listed in the Centers for Disease Control and Prevention’s Recommended Immunization Adult Schedule; A vaccination recommended in the Centers for Disease Control and Prevention’s Health Information for International Travel; A vaccination recommended for individuals between 7 years old and 18 years old by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices for Persons aged 0 through 18 years old; An influenza vaccination; A COVID vaccination; or A vaccination approved or authorized by the U.S. Food and Drug Administration. “Vaccine information statement” means the information sheet, produced by the Centers for Disease Control and Prevention that explains both the benefits and risks of a specific vaccine to the vaccine recipient, their parent, or their legal representative. 52:25 25-248-E (Regulations .02—.08) EMERGENCY ACTION IN EFFECT 11/20/2025 —5/19/2026 Registration. A licensed pharmacist shall submit a registration to the Board on the form that the Board requires. The registration form shall include verification from the licensed pharmacist of the following: That the pharmacist has completed a practical training program of at least 20 hours that is approved by the Accreditation Council for Pharmacy Education and includes education on: Hands-on injection techniques; Clinical evaluation of indication and contraindications of vaccines; The recognition and treatment of emergency reaction to vaccines; and Guidelines and recommendations of the Centers for Disease Control and Prevention regarding vaccinations in effect on December 31, 2024; and Possession of an active certification in basic cardiopulmonary resuscitation obtained through in-person classroom instruction. A registration authorizing a licensed pharmacist to administer vaccinations expires with the expiration of the license to practice pharmacy unless the licensed pharmacist has completed: Two hours of continuing education credits related to vaccinations; and All other requirements for licensure renewal. A licensed pharmacist may not administer vaccinations until the licensed pharmacist receives a written confirmation from the Board accepting the licensed pharmacist's registration. A licensed pharmacist may order and administer a vaccination in accordance with a protocol that meets the requirements of Regulation .06 of this chapter to an individual who is at least 3 years old provided that: The vaccine is: An influenza vaccine; A COVID vaccine; or Used in response to a public health emergency; and If the vaccination is administered to an individual under the age of 18 years, the pharmacist shall: Inform the child vaccination patient and the adult caregiver who is accompanying the child of the importance of well-child visits with a pediatric primary care provider; and Refer the child vaccination patient to a pediatric care provider when appropriate. A pharmacist may order and administer a vaccination in accordance with a protocol that meets the requirements of Regulation .06 of this chapter to an individual who is at least 7 years old provided that: The vaccine: Is recommended by the Center for Disease Control and Prevention Advisory Committee on Immunization Practices; or Approved or authorized by the U.S. Food and Drug Administration; and If the vaccination is administered to an individual under the age of 18 years, the pharmacist shall: Inform the child vaccination patient and the adult caregiver who is accompanying the child of the importance of well-child visits with a pediatric primary care provider; and Refer the child vaccination patient to a pediatric care provider when appropriate. The recommendations of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices cited in this regulation refer to federal statutes, rules, and guidance: In effect on December 31, 2024; or At a later date to account for any new vaccines recommended by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices after December 31, 2024. A licensed pharmacist may order and administer to an adult a vaccination in accordance with a protocol that meets the requirements of Regulation .06 of this chapter that is listed in the Center for Disease Control and Prevention’s Health Information for International Travel. A pharmacist shall report to the ImmuNet Program established under Health-General Article, §18-109, Annotated Code of Maryland, a vaccination administered by the pharmacist to an individual. A pharmacist shall: Have proof of active certification in basic cardiopulmonary resuscitation readily available. Provide the patient with a vaccine information statement issued by the Centers for Disease Control and Prevention; Obtain a signed consent form from the patient or custodial parent; and Observe the patient for a period of at least 15 minutes after administration of the vaccine for adverse effects including syncope. A pharmacy student in a Pharmacy Experiential Program, who has successfully completed a Board-approved certification course, may administer vaccinations under direct supervision of a licensed pharmacist who meets requirements in §A of this regulation. The pharmacy permit holder shall maintain documentation in the pharmacy from which the vaccine was administered for a minimum of 5 years that includes: The name, address, and date of birth of the individual receiving the vaccination; The date of administration and route and site of vaccinations; The name, dose, manufacturer’s lot number, and expiration date of the vaccine; The name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual; The name of the pharmacist, pharmacy student, physician, or nurse administering the vaccination; The version of the vaccination information statement provided to the individual receiving the vaccination; The copy of the signed patient consent form of those individuals to whom the vaccine was administered; The nature and outcome of an adverse reaction and documentation that the adverse reaction was reported to: The primary care provider; and The Vaccine Adverse Event Reporting System. At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered. The records required in this regulation shall be: Readily retrievable; Made available on the request of the Board; Except for records related to minor patients, maintained for a minimum of 5 years; and In the case of a minor patient, maintained until the patient attains the age of majority plus 3 years or for 5 years after the record is made, whichever is later. The pharmacist administering a vaccination as an independent provider at a location that is not a pharmacy shall maintain the following documentation for a minimum of 5 years: Name, address, and date of birth of the individual receiving the vaccination; Date of administration, and route and site of vaccinations; Name, dose, manufacturer's lot number, and expiration date of the vaccine; Name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual; Name of the pharmacist or pharmacy student administering the vaccination; Version of the vaccination information statement provided to the individual receiving the vaccination; Copy of the signed patient consent form of those individuals to whom the vaccine was administered; Nature and outcome of an adverse reaction, and documentation that the adverse reaction was reported to: The primary care provider; and The Vaccine Adverse Event Reporting System. At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered. The pharmacist administering a vaccination on behalf of a permit holder at a location that is not a pharmacy shall maintain the following documentation with the permit holder for a minimum of 5 years: Name, address, and date of birth of the individual receiving the vaccination; Date of administration, and route and site of vaccinations; Name, dose, manufacturer's lot number, and expiration date of the vaccine; Name and address of the primary health care provider of the individual receiving the vaccination, as identified by that individual; Name of the pharmacist or pharmacy student administering the vaccination; Version of the vaccination information statement provided to the individual receiving the vaccination; Copy of the signed patient consent form of those individuals to whom the vaccine was administered; Nature and outcome of an adverse reaction, and documentation that the adverse reaction was reported to: The primary care provider; and The Vaccine Adverse Event Reporting System. At least one effort made by the pharmacist to inform the individual’s authorized prescriber that the vaccination has been administered; and If the authorized prescriber is not the individual’s primary care provider or if the vaccination has not been administered in accordance with a prescription document, at least one effort made by the pharmacist to inform the individual’s primary care provider or other usual source of care that the vaccination has been administered. Every patient receiving a vaccination shall be provided with a current vaccine information statement. Every patient receiving a vaccination shall: Sign a consent form consenting to the administration of the vaccine; and Be given a copy of the consent form for the patient's future reference. The consent form shall disclose the credentials of the pharmacist administering the vaccination. A pharmacist shall have and maintain a written protocol for any vaccine to be administered, including influenza vaccination. The pharmacist shall administer vaccinations in accordance with the written protocol. The written protocol for each vaccine shall contain at least the following elements: Identity and license number of the participating pharmacist; Vaccine; Precautions to vaccine use; Contraindications to vaccine use; Process to be followed for screening for: Indications; Precautions; Contraindications; and Allergies; Process for obtaining and documenting consent; Process for verification of prescription for patients 11—17 years old for vaccinations other than the influenza vaccine; Dose or doses of the vaccine that will be administered; The route or routes and site or sites of administration of the vaccine; The injection or administration procedures; Post-vaccination procedures, including waiting requirements; Process for handling adverse reactions, including but not limited to: Acute anaphylactic reactions; and Other acute emergencies; and Process for documenting and maintaining a vaccination record including at least: Patient: Name; Date of birth; and Address; Vaccination administration: Date; Dose; Site; and Route; Vaccine: Manufacturer; Lot number; and Expiration date; Required Vaccine Information Statement: Version; and Provision date; Name of the patient’s primary care provider or prescriber; Documentation: Of at least one attempt to inform the patient’s primary care provider or prescriber that the vaccination has been administered; or That the patient has no primary care provider; Documentation of an attempt to inform the patient’s primary care provider that the influenza vaccination has been administered may not be required; and The name of the vaccinator. The protocol shall be: Signed and dated at least annually by the pharmacist; Available and presented for inspection to the Board of Pharmacy upon request; and Reviewed and updated as necessary. Fees charged for the administration of vaccinations may not exceed $50 in addition to the cost of each vaccination. Health Occupations Article, §§12-101, 12-102(b), 12-508, and 12-6A-10, Annotated Code of Maryland Effective date: Regulations .01—.07 adopted as an emergency provision effective December 16, 2005 (33:1 Md. R. 34); adopted permanently effective April 24, 2006 (33:8 Md. R. 734) Regulation .03A amended effective July 2, 2007 (34:13 Md. R. 1151) Regulation .08 adopted effective July 2, 2007 (34:13 Md. R. 1151) Chapter revised effective August 1, 2009 (36:15 Md. R. 1167) Regulation .03 amended as an emergency provision effective October 1, 2011 (38:24 Md. R. 1495); amended permanently effective January 23, 2012 (39:1 Md. R. 18) Chapter revised effective April 28, 2014 (41:8 Md. R. 472) Regulation .02B amended as an emergency provision effective November 20, 2025 (52:25 Md. R. 1266) Regulation .03 amended as an emergency provision effective November 20, 2025 (52:25 Md. R. 1266) Regulation .03D amended effective December 31, 2018 (45:26 Md. R. 1246) Regulations .04— .08 amended as an emergency provision effective November 20, 2025 (52:25 Md. R. 1266)